Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Retraction

Published on 06 Sep 2023

Retraction: MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway

in Gastrointestinal and Hepatic Pharmacology

Frontiers Editorial Office

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1285746

1,202 views

Original Research

Published on 06 Sep 2023

Glycyrrhizin arginine salt protects against cisplation-induced acute liver injury by repressing BECN1-mediated ferroptosis

in Gastrointestinal and Hepatic Pharmacology

Jun Guo
Jiameng Yin
Pu Liu
Xin Zhang
Jie Wei
Mingjun Wang
Yanxia Xiao
Yongzhan Zhen
Yajun Lin
Jian Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219486

2,784 views
6 citations

Correction

Published on 05 Sep 2023

Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib

in Gastrointestinal and Hepatic Pharmacology

Mohamed E. Shaker
Hesham A. M. Gomaa
Sara H. Hazem
Mohamed A. Abdelgawad
Mohamed El-Mesery
Ahmed A. Shaaban

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1281416

1,236 views

Clinical Trial

Published on 01 Sep 2023

Effects of acupuncture on gut microbiota and short-chain fatty acids in patients with functional constipation: a randomized placebo-controlled trial

in Gastrointestinal and Hepatic Pharmacology

Xiang-Yun Yan
Jun-Peng Yao
Yan-Qiu Li
Xian-Jun Xiao
Wan-Qing Yang
Si-Jue Chen
Tai-Chun Tang
Yu-Qing Yang
Liu Qu
Yu-Jun Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1223742

6,744 views
8 citations

Original Research

Published on 31 Aug 2023

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study

in Gastrointestinal and Hepatic Pharmacology

Fang Cheng
Xian-Gao Jiang
Shi-Lin Zheng
Te Wu
Qiang Zhang
Xin-Chun Ye
Saiduo Liu
Ji-Chan Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1171353

2,184 views
4 citations

Review

Published on 31 Aug 2023

Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects

in Gastrointestinal and Hepatic Pharmacology

Dan Shan
Siyu Dai
Qian Chen
Yupei Xie
Yayi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218432

6,057 views
5 citations

Review

Published on 30 Aug 2023

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women

in Gastrointestinal and Hepatic Pharmacology

ChenLu Zhao
JunHao Shi
DongFang Shang
Min Guo
Cheng Zhou
WenXia Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237845

3,792 views
2 citations

Review

Published on 29 Aug 2023

Therapeutic potential of sulforaphane in liver diseases: a review

in Gastrointestinal and Hepatic Pharmacology

Liang Yan
Yachun Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256029

9,283 views
10 citations

Original Research

Published on 28 Aug 2023

Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy

in Gastrointestinal and Hepatic Pharmacology

Qing-Zhou Kong
Cheng Peng
Zhen Li
Bao-Ling Tian
Yue-Yue Li
Fei-Xue Chen
Xiu-Li Zuo
Yan-Qing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184754

1,932 views
2 citations

Systematic Review

Published on 25 Aug 2023

Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Zeyi Zheng
Ziyu Lu
Yani Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244400

5,438 views
3 citations

Study Protocol

Published on 24 Aug 2023

Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial

in Gastrointestinal and Hepatic Pharmacology

Kyungha Min
Bumjo Oh
Hye Yeon Koo
Yang-Hyun Kim
Ji-Won Lee
Sangsub Lee
Youngah Kim
Hyuktae Kwon

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177539

3,102 views

Original Research

Published on 24 Aug 2023

YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

in Gastrointestinal and Hepatic Pharmacology

Zhan Jing-Lun
Chai Shuang
Zhao Li-Mei
Liu Xiao-Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205062

2,115 views
4 citations

Review

Published on 23 Aug 2023

The role of gut microbiota and drug interactions in the development of colorectal cancer

in Gastrointestinal and Hepatic Pharmacology

Jinna Wu
Cong Xia
Can Liu
Qianshi Zhang
Chenglai Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265136

3,562 views
4 citations

Original Research

Published on 17 Aug 2023

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib

in Gastrointestinal and Hepatic Pharmacology

Yan Wu
Meihao Wei
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200254

6,754 views
11 citations

Original Research

Published on 17 Aug 2023

A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab

in Gastrointestinal and Hepatic Pharmacology

Xuan Shi
Jia-Hui Wang
Sheng-Xiang Rao
Tao-Tao Liu
Hao Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1246657

2,292 views
3 citations

Review

Published on 17 Aug 2023

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Yi Yuan
Dailin Wu
Jing Li
Dan Huang
Yan Zhao
Tianqi Gao
Zhenjie Zhuang
Ying Cui
Da-Yong Zheng
Ying Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217400

7,774 views
9 citations